Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 4
2004 4
2005 4
2006 7
2007 4
2008 5
2009 4
2010 5
2011 8
2012 3
2013 4
2014 6
2015 4
2016 4
2017 6
2018 3
2019 4
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

79 results
Results by year
Filters applied: . Clear all
Page 1
Influenza drug resistance.
Pizzorno A, Abed Y, Boivin G. Pizzorno A, et al. Among authors: abed y. Semin Respir Crit Care Med. 2011 Aug;32(4):409-22. doi: 10.1055/s-0031-1283281. Epub 2011 Aug 19. Semin Respir Crit Care Med. 2011. PMID: 21858746 Review.
Influenza virus resistance to neuraminidase inhibitors.
Samson M, Pizzorno A, Abed Y, Boivin G. Samson M, et al. Among authors: abed y. Antiviral Res. 2013 May;98(2):174-85. doi: 10.1016/j.antiviral.2013.03.014. Epub 2013 Mar 22. Antiviral Res. 2013. PMID: 23523943 Review.
Impact of the Baloxavir-Resistant Polymerase Acid I38T Substitution on the Fitness of Contemporary Influenza A(H1N1)pdm09 and A(H3N2) Strains.
Checkmahomed L, M'hamdi Z, Carbonneau J, Venable MC, Baz M, Abed Y, Boivin G. Checkmahomed L, et al. Among authors: abed y. J Infect Dis. 2020 Jan 1;221(1):63-70. doi: 10.1093/infdis/jiz418. J Infect Dis. 2020. PMID: 31419295
A Review of Clinical Influenza A and B Infections With Reduced Susceptibility to Both Oseltamivir and Zanamivir.
Abed Y, Boivin G. Abed Y, et al. Open Forum Infect Dis. 2017 May 18;4(3):ofx105. doi: 10.1093/ofid/ofx105. eCollection 2017 Summer. Open Forum Infect Dis. 2017. PMID: 28852674 Free PMC article. Review.
Reduced Susceptibility to Neuraminidase Inhibitors in Influenza B Isolate, Canada.
Abed Y, Fage C, Lag├╝e P, Carbonneau J, Papenburg J, Vinh DC, Boivin G. Abed Y, et al. Emerg Infect Dis. 2019 Apr;25(4):838-840. doi: 10.3201/eid2504.181554. Emerg Infect Dis. 2019. PMID: 30882323 Free PMC article.
Synergistic PA and HA mutations confer mouse adaptation of a contemporary A/H3N2 influenza virus.
Baz M, M'hamdi Z, Carbonneau J, Lavigne S, Couture C, Abed Y, Boivin G. Baz M, et al. Among authors: abed y. Sci Rep. 2019 Nov 12;9(1):16616. doi: 10.1038/s41598-019-51877-4. Sci Rep. 2019. PMID: 31719554 Free PMC article.
In Vitro Properties and Virulence of Contemporary Recombinant Influenza B Viruses Harboring Mutations of Cross-Resistance to Neuraminidase Inhibitors.
Fage C, Abed Y, Checkmahomed L, Venable MC, Boivin G. Fage C, et al. Among authors: abed y. Viruses. 2018 Dec 22;11(1):6. doi: 10.3390/v11010006. Viruses. 2018. PMID: 30583488 Free PMC article.
Molecular pathway of influenza pan-neuraminidase inhibitor resistance in an immunocompromised patient.
Abed Y, Schibler M, Checkmahomed L, Carbonneau J, Venable MC, Fage C, Giannotti F, Goncalves AR, Kaiser L, Boivin G. Abed Y, et al. Antivir Ther. 2019;24(8):581-587. doi: 10.3851/IMP3344. Antivir Ther. 2019. PMID: 32031540
Impact of R152K and R368K neuraminidase catalytic substitutions on in vitro properties and virulence of recombinant A(H1N1)pdm09 viruses.
Tu V, Abed Y, Fage C, Baz M, Boivin G. Tu V, et al. Among authors: abed y. Antiviral Res. 2018 Jun;154:110-115. doi: 10.1016/j.antiviral.2018.04.009. Epub 2018 Apr 16. Antiviral Res. 2018. PMID: 29674164
Treatment of respiratory virus infections.
Abed Y, Boivin G. Abed Y, et al. Antiviral Res. 2006 Jun;70(2):1-16. doi: 10.1016/j.antiviral.2006.01.006. Epub 2006 Feb 14. Antiviral Res. 2006. PMID: 16513187 Free PMC article. Review.
79 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page